94-17150. Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-The-Counter Human Use; Amendment of Final Monograph for OTC Antitussive Drug Products; Correction  

  • [Federal Register Volume 59, Number 135 (Friday, July 15, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-17150]
    
    
    [[Page Unknown]]
    
    [Federal Register: July 15, 1994]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 341
    
    [Docket No. 89P-0040]
    RIN 0905-AA06
    
     
    
    Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug 
    Products for Over-The-Counter Human Use; Amendment of Final Monograph 
    for OTC Antitussive Drug Products; Correction
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule; correction.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is correcting a final 
    rule that appeared in the Federal Register of June 3, 1994 (59 FR 
    29172). The document amended the final monograph for over-the-counter 
    (OTC) antitussive drug products to include the ingredients 
    diphenhydramine citrate and diphenhydramine hydrochloride. The document 
    was published with some errors. This document corrects those errors.
    
    EFFECTIVE DATE: June 5, 1995.
    
    FOR FURTHER INFORMATION CONTACT: William E. Gilbertson, Center for Drug 
    Evaluation and Research (HFD-810), Food and Drug Administration, 5600 
    Fishers Lane, Rockville, MD 20857, 301-594-5000.
    
        In FR Doc. 94-13586, appearing on page 29172 in the Federal 
    Register of Friday, June 3, 1994, the following corrections are made:
    
    
    Sec. 341.74  [Corrected]
    
        1. On page 29174, in the third column, in Sec. 341.74 Labeling of 
    antitussive drug products, paragraphs (d)(1)(iv) and (d)(1)(v) are 
    corrected by removing the quotation marks.
    
    
    Sec. 341.90  [Corrected]
    
        2. On page 29174, in the third column, in Sec. 341.90 Professional 
    labeling, paragraphs (r) and (s) are corrected by removing the 
    quotation marks.
    
        Dated: July 8, 1994.
    Michael R. Taylor,
    Deputy Commissioner for Policy.
    [FR Doc. 94-17150 Filed 7-14-94; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
07/15/1994
Department:
Food and Drug Administration
Entry Type:
Uncategorized Document
Action:
Final rule; correction.
Document Number:
94-17150
Dates:
June 5, 1995.
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: July 15, 1994, Docket No. 89P-0040
RINs:
0905-AA06
CFR: (2)
21 CFR 341.74
21 CFR 341.90